V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20224674 | 20084967 | 1.7 | 94 | Neo-adjuvant (N) | 2018-06-27 | 2018-07-04 | Enzalutamide | 2 | N | OXALIPLATIN + RALTITREXED | 100311187 |
| 20224679 | 20084968 | 1.94 | 59.8 | Palliative (P) | 2018-08-09 | 2018-08-30 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101683231 |
| 20224681 | 20084969 | 1.7 | 71 | Palliative (P) | 2018-08-13 | 2018-08-14 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101170329 |
| 20224689 | 20084970 | 1.8 | 84 | null | 2020-02-09 | 2020-02-10 | Cisplatin | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100033728 |
| 20224690 | 20084971 | 0 | 0 | Palliative (P) | 2019-04-15 | 2019-04-15 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100432712 |
| 20224691 | 20084972 | 1.78 | 106.4 | Palliative (P) | 2020-03-13 | 2020-03-15 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101863345 |
| 20224692 | 20084973 | 1.66 | 92.4 | Palliative (P) | 2019-08-17 | 2019-08-17 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100419351 |
| 20224698 | 20084974 | 1.71 | 56 | null | 2018-02-25 | 2018-03-05 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100350150 |
| 20224700 | 20084975 | 1.78 | 54.7 | Palliative (P) | 2017-06-01 | 2017-06-03 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100320879 |
| 20224706 | 20084976 | 1.65 | 89.7 | Palliative (P) | 2016-09-29 | 2016-10-27 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100323849 |
| 20224714 | 20084977 | 0 | 64 | Palliative (P) | 2019-04-30 | 2019-05-10 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101817298 |
| 20224715 | 20084978 | 1.64 | 80.5 | Neo-adjuvant (N) | 2017-01-06 | 2017-01-08 | Enzalutamide | 02 | N | CARBOPLATIN | 101152052 |
| 20224717 | 20084979 | null | 89 | Neo-adjuvant (N) | 2017-02-13 | 2017-02-13 | Enzalutamide | 02 | N | CETUXIMAB | 100247478 |
| 20224727 | 20084980 | 1.61 | 45 | Palliative (P) | 2015-03-22 | 2015-04-05 | Enzalutamide | 02 | N | CARBOPLATIN | 100549437 |
| 20224729 | 20084981 | 1.78 | 0 | Palliative (P) | 2019-01-31 | 2019-01-31 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101570767 |
| 20224731 | 20084982 | 1.71 | 47 | Neo-adjuvant (N) | 2018-10-04 | 2018-10-04 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100976054 |
| 20224732 | 20084983 | 1.66 | 66.2 | Palliative (P) | 2020-05-27 | 2020-05-27 | OCTREOTIDE | 02 | N | TRASTUZUMAB | 101281448 |
| 20224734 | 20084984 | 1.8 | 0 | Curative (C) | null | 2021-01-13 | OCTREOTIDE | 02 | N | SCALOP-2 TRIAL | 100902920 |
| 20224737 | 20084985 | 1.56 | 75.4 | Palliative (P) | 2018-08-07 | 2018-08-07 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CARBOPLATIN | 100509326 |
| 20224738 | 20084986 | null | 114 | Disease modification (D) | 2016-06-10 | 2016-06-12 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101132101 |
| 20224743 | 20084987 | 1.67 | 75.8 | Palliative (P) | 2016-10-28 | 2016-10-28 | Enzalutamide | 1 | N | TRASTUZUMAB | 100758711 |
| 20224747 | 20084988 | 1.7 | 60.7 | Palliative (P) | 2019-12-16 | 2020-01-22 | Cisplatin | 02 | N | CISPLATIN | 100432942 |
| 20224749 | 20084989 | 1.75 | 67 | Curative (C) | 2016-03-06 | 2016-03-06 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100259696 |
| 20224754 | 20084990 | 1.7 | 56.9 | Neo-adjuvant (N) | 2016-10-01 | 2016-10-20 | Enzalutamide | null | N | CAPECITABINE + TEMOZOLOMIDE | 100374985 |
| 20224756 | 20084991 | 1.76 | null | Palliative (P) | 2019-04-09 | 2019-04-30 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101464262 |
| 20224758 | 20084992 | 1.7 | 67.7 | Curative (C) | 2018-05-12 | 2018-06-30 | Capecitabine + Cisplatin + RT | 02 | Y | OCTREOTIDE | 100149744 |
| 20224765 | 20084993 | 1.72 | null | Palliative (P) | 2018-01-12 | 2018-01-26 | Enzalutamide | N | Y | CAPECITABINE + TEMOZOLOMIDE | 100439967 |
| 20224766 | 20084994 | 1.78 | 105 | null | 2017-06-22 | 2017-06-29 | Enzalutamide | 2 | null | CAPECITABINE + TEMOZOLOMIDE | 101041523 |
| 20224768 | 20084995 | 1.59 | 59 | Curative (C) | 2016-12-28 | 2016-12-28 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100177448 |
| 20224775 | 20084996 | 1.85 | 91.2 | Palliative (P) | 2017-08-16 | 2017-08-20 | Carboplatin AUC 2 - 5 | 02 | N | ECF | 101158395 |
| 20224785 | 20084997 | 1.65 | 75 | Palliative (P) | 2018-12-21 | 2018-12-22 | Enzalutamide | 02 | N | CARBOPLATIN | 101802050 |
| 20224789 | 20084998 | 1.78 | 68 | null | null | 2019-02-14 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100013780 |
| 20224792 | 20084999 | 1.52 | 48 | Curative (C) | 2017-06-02 | 2017-06-14 | Enzalutamide | null | N | ENZALUTAMIDE | 101433890 |
| 20224794 | 20085000 | 1.67 | 62.8 | Neo-adjuvant (N) | 2018-01-06 | 2018-01-15 | GEMCARBO | 02 | Y | CARBOPLATIN + GEMCITABINE | 100976867 |
| 20224798 | 20085001 | 0 | 0 | null | 2019-05-17 | 2019-05-17 | Enzalutamide | 02 | null | ECF | 101095282 |
| 20224803 | 20085002 | 1.76 | 79.7 | Curative (C) | 2016-12-15 | 2016-12-15 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101861479 |
| 20224810 | 20085003 | 1.68 | 63.8 | Adjuvant (A) | 2021-08-02 | 2021-08-10 | Enzalutamide | 02 | Y | CAPECITABINE + TEMOZOLOMIDE | 100372471 |
| 20224828 | 20085004 | 1.56 | 67 | Palliative (P) | 2018-10-23 | 2018-11-18 | GemCarbo Days 1+8 | 02 | Y | CARBOPLATIN + GEMCITABINE | 100020808 |
| 20224829 | 20085005 | 1.71 | 85 | Palliative (P) | 2017-10-11 | 2017-10-24 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100465200 |
| 20224830 | 20085006 | null | 101.3 | null | null | 2017-05-27 | Mitomycin Intravesical | N | null | MITOMYCIN INTRAVESICULAR | 101110961 |
| 20224831 | 20085007 | 0 | 0 | Palliative (P) | 2019-11-06 | 2019-11-26 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101076822 |
| 20224837 | 20085008 | 1.68 | 64 | null | 2019-05-14 | 2019-05-15 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101610134 |
| 20224846 | 20085009 | 1.53 | 66.5 | Adjuvant (A) | 2016-06-06 | 2016-06-14 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | TRASTUZUMAB | 100037646 |
| 20224849 | 20085010 | 1.74 | 114 | Adjuvant (A) | 2017-08-25 | 2017-09-16 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100282323 |
| 20224856 | 20085011 | 1.69 | 71.6 | 03 | 2014-10-06 | 2014-10-06 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101447587 |
| 20224857 | 20085012 | 1.8 | 68.3 | Palliative (P) | 2018-06-28 | 2018-06-28 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100499662 |
| 20224859 | 20085013 | 1.7 | 71 | Adjuvant (A) | 2017-12-12 | 2017-12-30 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100893152 |
| 20224861 | 20085014 | 1.62 | 70.3 | Palliative (P) | 2019-10-30 | 2019-12-17 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | ECF | 101082854 |
| 20224871 | 20085015 | 1.74 | 143 | Palliative (P) | 2019-06-12 | 2019-06-12 | Enzalutamide | 02 | N | CETUXIMAB | 101178172 |
| 20224878 | 20085016 | null | 108.1 | null | 2017-06-30 | 2017-07-04 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101674542 |